Topics
Glioblastoma | Etiopathogenesis | Overview
Home > Publications > Topics > Glioblastoma > Etiopathogenesis > Overview
Mathur R, Wang Q, Schupp PG, Nikolic A, Hilz S, Hong C, Grishanina
NR, Kwok D, Stevers NO, Jin Q, Youngblood MW, Stasiak LA, Hou Y,
Wang J, Yamaguchi TN, Lafontaine M, Shai A, Smirnov IV, Solomon
DA, Chang SM, Hervey-Jumper SL, Berger MS, Lupo JM, Okada H,
Phillips JJ, Boutros PC, Gallo M, Oldham MC, Yue F, Costello
JF.
Glioblastoma evolution and
heterogeneity from a 3D whole-tumor perspective.
Cell.
2024 Jan 18;187(2):446-463.e16. doi:
10.1016/j.cell.2023.12.013. PMID:
38242087. Laboratory investigation.
ˍ
RELATED
ARTICLE
Baig
S, Winkler F.
A
holistic view of the malignant organism we call
glioblastoma.
Cell.
2024 Jan 18;187(2):271-273. doi:
10.1016/j.cell.2023.12.021. PMID:
38242083. Comment˰ ˍ
Okamoto T, Mizuta R, Takahashi Y, Otani Y, Sasaki E, Horio Y,
Kuroda H, Matsushita H, Date I, Hashimoto N, Masago K.
Genomic
landscape of glioblastoma without IDH somatic mutation in 42
cases: a comprehensive analysis using RNA sequencing data.
J
Neurooncol. 2024 Apr 23. doi:
10.1007/s11060-024-04628-z. PMID:
38653957. Laboratory investigation˰
ˍ
Dakal TC, Kakde GS, Maurya PK.
Genomic,
epigenomic and transcriptomic
landscape of glioblastoma.
Metab
Brain Dis. 2024 Aug 24. doi:
10.1007/s11011-024-01414-8. PMID:
39180605. Review˰ ˍ